Literature DB >> 24979093

Functional capacity, strength, and quality of life in children and youth with familial Mediterranean fever.

Gamze Alayli1, Dilek Durmus, Ozan Ozkaya, Halil Erdinc Sen, Hulya Nalcacioglu, Ayhan Bilgici, Omer Kuru.   

Abstract

PURPOSE: To examine functional capacity and muscle strength in children and youth with familial Mediterranean fever (FMF) as compared with controls, and to assess whether these factors influence quality of life (QOL) in FMF.
METHODS: A total of 100 subjects with FMF and 55 control subjects (8-18 years old) without known health issues were enrolled in the study. The 6-Minute Walk Test (6MWT) was used to evaluate functional capacity. Quadriceps strength was measured with a hand-held dynamometer. Quality of life was evaluated with the Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0).
RESULTS: Significant differences were found between subjects with FMF and controls in the 6MWT and strength test. PedsQL scores of subjects with FMF were significantly lower than the scores of the controls. The 6MWT and quadriceps strength were weakly correlated with the PedsQL.
CONCLUSION: Subjects with FMF displayed lower functional capacity and QOL than peers who are healthy. Decreased functional capacity was correlated with decreased QOL in those with FMF.

Entities:  

Mesh:

Year:  2014        PMID: 24979093     DOI: 10.1097/PEP.0000000000000052

Source DB:  PubMed          Journal:  Pediatr Phys Ther        ISSN: 0898-5669            Impact factor:   3.049


  6 in total

1.  Number of Episodes Can Be Used as a Disease Activity Measure in Familial Mediterranean Fever.

Authors:  David Piskin; Zehra Serap Arici; Dilek Konukbay; Micol Romano; Balahan Makay; Nuray Ayaz; Yelda Bilginer; Roberta A Berard; Hakan Poyrazoglu; Ozgur Kasapcopur; Ronald M Laxer; Kathy Speechley; Erkan Demirkaya
Journal:  Front Pediatr       Date:  2022-04-27       Impact factor: 3.569

2.  Does Familial Mediterranean Fever Provoke Atherosclerosis in Children? Evaluation of Arterial Stiffness and Serum Endocan Levels.

Authors:  Serkan Türkuçar; Kaan Yıldız; Tuncay Küme; Ceyhun Açarı; Hatice Adıgüzel Dundar; Balahan Makay; Mustafa Kır; Erbil Ünsal
Journal:  Clin Rheumatol       Date:  2021-04-04       Impact factor: 2.980

3.  Familial Mediterranean fever: Health-related quality of life and associated variables in a national cohort.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Mehmet Tuncay Duruöz; Hasan Fatih Çay; Ülkü Uçar; Yaşar Keskin; Betül Sargin; Gülcan Gürer; Ozan Volkan Yurdakul; Mustafa Çaliş; Hülya Deveci; Yıldıray Aydin; Sami Hizmetli; Remzi Çevik; Ali Yavuz Karahan; Şebnem Ataman; Hilal Ecesoy; Zafer Günendi; Murat Toprak; Nesrin Şen; Duygu Altintaş; Ahmet Kıvanç Cengiz; Gökhan Çağlayan; Ali Nail Demir; Hüseyin Kaplan; Sertaç Ketenci; Meltem Alkan Melikoğlu; Mehmet Nayimoğlu; Kemal Nas; Banu Sarifakioğlu; İlhan Sezer
Journal:  Arch Rheumatol       Date:  2020-12-10       Impact factor: 1.472

4.  Evaluation of quality of life and its associations with clinical parameters in pediatric patients with familial Mediterranean fever.

Authors:  Deniz Gezgin Yildirim; Sevcan Azime Bakkaloglu; A Sebnem Soysal Acar; Bulent Celik; Necla Buyan
Journal:  North Clin Istanb       Date:  2021-04-26

5.  Medical Cannabis in Treatment of Resistant Familial Mediterranean Fever.

Authors:  George Habib; Uriel Levinger
Journal:  Am J Case Rep       Date:  2019-09-10

6.  Decreased exercise capacity, strength, physical activity level and quality of life in adult patients with familial Mediterranean fever

Authors:  Nurten Gizem Tore; Fulden Sari; Devrim Can Saraç; Selin Bayram; Hasan Satış; Hazan Karadeniz; Abdurrahman Tufan; Deran Oskay
Journal:  Turk J Med Sci       Date:  2021-08-30       Impact factor: 0.973

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.